Simultaneous determination of 25 common pharmaceuticals in whole blood using ultra-performance liquid chromatography-tandem mass spectrometry

Journal of Analytical Toxicology

Volumn 36, Issue 7, 2012, Pages 497-506

  Klose Nielsen, Marie Katrine ^a   Johansen, Sys Stybe ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ACETONITRILE; AMITRIPTYLINE; ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUTYL ACETATE; CHLORPROTHIXENE; CITALOPRAM; DIBENZEPIN; FLUOXETINE; FORMIC ACID; LAMOTRIGINE; LEVOMEPROMAZINE; LIDOCAINE; METHYLPHENIDATE; METOCLOPRAMIDE; METOPROLOL; MIANSERIN; MIRTAZAPINE; NEUROLEPTIC AGENT; NORFLUOXETINE; NORTRIPTYLINE; ORPHENADRINE; OXYCODONE; PAROXETINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZUCLOPENTHIXOL;

ACCURACY; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; DRUG DETERMINATION; FORENSIC TOXICOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTERMETHOD COMPARISON; LIMIT OF QUANTITATION; LIQUID LIQUID EXTRACTION; PH; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION STUDY;

EID: 84871097606     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bks054     Document Type: Article

References (25)

1. Gunnar, T., Ariniemi, K., Lillsunde, P. (2005) Validated toxicological determination of 30 drugs of abuse as optimized derivatives in oral fluid by long column fast gas chromatography/electron impact mass spectrometry. Journal of Mass Spectrometry, 40, 739-753.
2. Kraemer, T., Paul, L. (2007) Bioanalytical procedures for determination of drugs of abuse in blood. Analytical and Bioanalytical Chemistry, 388, 1415-1435.
3. Moeller, M.R., Kraemer, T. (2002) Drugs of abuse monitoring in blood for control of driving under the influence of drugs. Therapeutic Drug Monitoring, 24, 210-221.
4. Bjørk, M.K., Nielsen, M.K.K, Markussen, L.Ø., Klinke, H.B., Linnet, K. (2010) Determination of 19 drugs of abuse and metabolites in whole blood by high-performance liquid chromatography-tandem mass spectrometry. Analytical and Bioanalytical Chemistry, 396, 2392-2401.
5. Gergov, M., Nokua, P., Vuori, E., Ojanper, I. (2009) Simultaneous screening and quantification of 25 opioid drugs in post-mortem blood and urine by liquid chromatography-tandem mass spectrometry, Forensic Science International, 186, 36-43.
6. Kratzsch, C., Tenberken, O., Peters, F.T., Weber, A.A., Kraemer, T., Maurer, H.H. (2004) Screening, library-assisted identification and validated quantification of 23 benzodiazepines, flumazenil, zaleplone, zolpidem and zopiclone in plasma by liquid chromatography-mass spectrometry with atmospheric pressure chemical ionization. Journal of Mass Spectrometry, 39, 856-872.
7. Maurer, H.H., Tenberken, O., Kratzsch, C., Weber, A.A., Peters, F.T. (2004) Screening for library-assisted identification and fully validated quantification of 22 beta-blockers in blood plasma by liquid chromatography-mass spectrometry with atmospheric pressure chemical ionization. Journal of Chromatography A, 1058, 169-181.
8. Musshoff, F., Lachenmeier, K., Wollersen, H., Lichtermann, D., Madea, B. Opiate concentrations in hair from subjects in a controlled heroin-maintenance program and from opiate-associated fatalities. Journal of Analytical Toxicology, 29, 345-352 (2005).
9. Schulz, M., Schmoldt, A. (2003) Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Pharmazie, 58, 447-474.
10. Therapeutic and Toxic Drug Concentrations List, www.tiaft.org/tmembers/ttv/ttv_all.html (May 2005).
11. Eeckhaut, A.V., Lanckmans, K., Sarre, S., Smolders, I., Michotte, Y. (2009) Validation of bioanalytical LC-MS/MS assays: Evaluation of matrix effects. Journal of Chromatography B, 877, 2198-2207.
12. Mallet, C.R., Lu, Z., Mazzeo, J.R. (2004) A study of ion suppression effects in electrospray ionization from mobile phase additives and solid-phase extracts. Rapid Communications in Mass Spectrometry, 18, 49-58.
13. Matuszewski, B., Constanzer, M., Chavez-Eng, C. (2003) Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Analytical Chemistry, 75, 3019-3030.
14. Badawi, N., Simonsen, K.W., Steentoft, A., Bernhoft, I.M., Linnet, K. (2009) Simultaneous screening and quantification of 29 drugs of abuse in oral fluid by solid-phase extraction and ultraperformance LC-MS-MS. Clinical Chemistry, 55, 2004-2018.
15. Remane, D., Meyer, M.R., Wissenbach, D.K., Maurer, H.H. (2010) Ion suppression and enhancement effects of co-eluting analytes in multi-analyte approaches: Systematic investigation using ultra-highperformance liquid chromatography-mass spectrometry with atmospheric-pressure chemical ionization or electrospray ionization. Rapid Communications in Mass Spectrometry, 24, 3103-3108.
16. Remane, D., Meyer, M.R., Peters, F.T., Wissenbach, D.K., Maurer, H.H. (2010) Fast and simple procedure for liquid-liquid extraction of 136 analytes from different drug classes for development of a liquid chromatographic-tandem mass spectrometric quantification method in human blood plasma. Analytical and Bioanalytical Chemistry, 397, 2303-2314.
17. Remane, D., Meyer, M.R., Wissenbach, D.K., Maurer, H.H. (2011) Full validation and application of an ultra-high performance liquid chromatographic-tandem mass spectrometric procedure for target screening and quantification of 34 antidepressants in human blood plasma as part of a comprehensive multi-analyte approach. Analytical and Bioanalytical Chemistry, 400, 2093-2107.
18. Simonsen, K.W., Hermansson, S., Steentoft, A., Linnet, K. (2010) A validated method for simultaneous screening and quantification of twenty-three benzodiazepines and metabolites plus zopiclone and zaleplone in whole blood by liquid-liquid extraction ultraperformance liquid chromatography-tandem mass spectrometry. Journal of Analytical Toxicology, 34, 332-341.
19. Oiestad, E.L., Johansen, U., Oiestad, A.M.L., Christophersen, A.S. (2011) Drug screening of whole blood by ultra-performance liquid chromatography-tandem mass spectrometry. Journal of Analytical Toxicology, 35, 280-293.
20. Araujo, P. (2009) Key aspects of analytical method validation and linearity evaluation. Journal of Chromatography B, 877, 2224-2234.
21. Peters, F.T., Drummer, O.H., Musshoff, F. (2007) Validation of new methods. Forensic Science International, 165, 216-224.
22. Metodevalidering i kemiske analytiske laboratorier. Kvantitative analysemetoder. http://www2.danak.dk/akkreditering/RL/RL1.pdf (September 2008).
23. Dalsgaard, P.W., Rasmussen, B.S., Müller, I.B., Linnet, K. Toxicological screening of basic drugs in whole blood using UPLC-TOF-MS. Drug Testing and Analysis, September 13, 2011: 10.1002/dta.303.
24. Linnet, K., Johansen, S.S., Buchard, A., Munkholm, J., Morling, N. (2008) Dominance of pre-analytical over analytical variation for measurement of methadone and its main metabolite in postmortem femoral blood. Forensic Science International, 179, 78-82.
25. Peters, F.T., Maurer, H.H. (2007) Systematic comparison of bias and precision data obtained with multiple-point and one-point calibration in six validated multianalyte assays for quantification of drugs in human plasma. Analytical Chemistry, 79, 4967-4976.